Victory Capital Management Inc Bridge Bio Pharma, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 348,357 shares of BBIO stock, worth $8.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

348,357

Previous 459,569 24.2%

Holding current value

$8.82 Million

Previous $18.6 Million 41.94%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$27.35 - $40.45 $3.04 Million - $4.5 Million	-111,212 Reduced 24.2%	348,357 $10.8 Million
Q4 2023 Feb 05, 2024	BUY	$24.02 - $43.89 $580,227 - $1.06 Million	24,156 Added 5.55%	459,569 $18.6 Million
Q3 2023 Nov 06, 2023	SELL	$16.89 - $35.01 $2 Million - $4.14 Million	-118,320 Reduced 21.37%	435,413 $11.5 Million
Q2 2023 Jul 27, 2023	BUY	$13.29 - $18.01 $7.2 Million - $9.76 Million	541,690 Added 4497.97%	553,733 $9.52 Million
Q1 2023 May 02, 2023	SELL	$7.17 - $18.55 $525,224 - $1.36 Million	-73,253 Reduced 85.88%	12,043 $199,000

Q4 2022 Feb 09, 2023	SELL	$6.74 - $11.52 $449,052 - $767,520	-66,625 Reduced 43.86%	85,296 $649,000
Q3 2022 Nov 02, 2022	BUY	$7.94 - $12.36 $401,414 - $624,872	50,556 Added 49.88%	151,921 $1.51 Million
Q2 2022 Aug 01, 2022	BUY	$5.21 - $12.14 $4,944 - $11,520	949 Added 0.95%	101,365 $920,000
Q1 2022 May 04, 2022	SELL	$7.34 - $17.16 $11,766 - $27,507	-1,603 Reduced 1.57%	100,416 $989,000
Q4 2021 Feb 07, 2022	BUY	$11.38 - $53.41 $1.04 Million - $4.86 Million	91,010 Added 826.69%	102,019 $1.7 Million
Q3 2021 Nov 02, 2021	SELL	$46.87 - $64.24 $13,264 - $18,179	-283 Reduced 2.51%	11,009 $516,000
Q2 2021 Aug 03, 2021	SELL	$46.47 - $63.93 $59,992 - $82,533	-1,291 Reduced 10.26%	11,292 $688,000
Q1 2021 May 04, 2021	BUY	$55.47 - $72.35 $71,556 - $93,331	1,290 Added 11.42%	12,583 $775,000
Q4 2020 Feb 01, 2021	BUY	$38.38 - $71.11 $30,281 - $56,105	789 Added 7.51%	11,293 $803,000
Q3 2020 Nov 09, 2020	SELL	$27.2 - $42.19 $1.89 Million - $2.93 Million	-69,456 Reduced 86.86%	10,504 $394,000
Q2 2020 Aug 07, 2020	SELL	$22.22 - $35.69 $156,117 - $250,757	-7,026 Reduced 8.08%	79,960 $2.61 Million
Q1 2020 May 04, 2020	SELL	$16.11 - $36.23 $53,227 - $119,703	-3,304 Reduced 3.66%	86,986 $2.52 Million
Q4 2019 Feb 06, 2020	BUY	$17.96 - $46.63 $933 - $2,424	52 Added 0.06%	90,290 $3.17 Million
Q4 2019 Feb 04, 2020	SELL	$17.96 - $46.63 $12.8 Million - $33.2 Million	-711,751 Reduced 88.75%	90,238 $3.11 Million
Q3 2019 Nov 12, 2019	BUY	$20.13 - $32.38 $3.43 Million - $5.51 Million	170,200 Added 26.94%	801,989 $17.2 Million
Q2 2019 Aug 15, 2019	BUY	$26.97 - $27.55 $17 Million - $17.4 Million	631,789 New	631,789 $17 Million

Others Institutions Holding BBIO

# of Institutions

284

Shares Held

170M

Call Options Held

7.41M

Put Options Held

2.61M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Bridge Bio Pharma, Inc. Transaction History